Stöber, Alisa http://orcid.org/0000-0001-6368-0662
Marijic, Pavo http://orcid.org/0000-0002-6321-7296
Kurz, Christoph http://orcid.org/0000-0001-9498-8002
Schwarzkopf, Larissa http://orcid.org/0000-0002-9402-7700
Kirsch, Florian http://orcid.org/0000-0003-0543-592X
Schramm, Anja http://orcid.org/0000-0002-4703-2355
Leidl, Reiner http://orcid.org/0000-0002-7115-7510
Funding for this research was provided by:
Gemeinsame Bundesausschuss (01VSF16025)
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Article History
Received: 4 April 2022
Accepted: 22 December 2022
First Online: 13 January 2023
Declarations
:
: Prof. Dr. Reiner Leidl declares grants from the Innovation Fund, Federal Joint Committee, Germany, during the conduct of the study. The other authors declare they have no conflict of interests.
: The study has been approved by the ethics committee of the Ludwig-Maximilians-University, Munich, Germany (vote no. 17–358) and complies with the Declaration of Helsinki. Written informed consent was given by all participants at the time of inclusion in the disease management program.